View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters
Reset Filters

Structural Targeting of TREM2 in Alzheimer's Disease

Thomas Brett, Ph.D.
St. Louis , MO - United States
2025

Defining Short RNA Therapeutics that Reverse TDP-43 Proteinopathy

James Shorter, Ph.D.
Philadelphia, PA - United States
2025

Moving Beyond Amyloid and Tau to Capture the Biological Heterogeneity of Alzheimer's Disease

Tracy Young-Pearse, Ph.D.
Cambridge, MA - United States
2025

Aging and Dementia Research and Training (ADRET) Program in Uganda

Francis Bajunirwe, Ph.D.
Mbarara, Uganda
2024

U.S. POINTER Alumni Extension

Laura Baker
Winston-Salem, NC - United States
2024

Impaired Neuronal Cytoarchitecture in AD/ADRD

Merci Best, Ph.D.
Ann Arbor, MI - United States
2024

Relationship Between Sleep, Tau, and Race in Preclinical Alzheimer disease

Anthony Briggs, Ph.D.
New York, NY - United States
2024

Investigating the Neurophysiologic Impact of Amyloid Removal Therapy in AD

Stephanie Buss, M.D.
Boston, MA - United States
2024

Fostering Equitable Dementia Care for Hispanic/Latino Communities

Sara Bybee, Ph.D.
Salt Lake City, UT - United States
2024

Proteomics Profiling of Microglia for Cognitive Resilience in AD

Yu Chen, Ph.D.
Ann Arbor, MI - United States
2024

Developing CRISPR genome therapy for Alzheimer's disease

Claire Clelland, M.D, Ph.D.
San Francisco, CA - United States
2024

Epidemiology and deep phenotyping of Argentinian patients with tauopathies

Blas Couto, Ph.D.
Buenos Aires, Argentina
2024

Resilience in Andean American Indigenous with Alzheimer's disease

Nilton Custodio, M.D., Ph.D.
Lima, Peru
2024

Genetic and environmental contributions to longitudinal tau trajectories

Anouk den Baraber, Ph.D.
Amsterdam, Netherlands
2024

Racial Residential Segregation, Neighborhood Deprivation and ADRD Risk

Paola Filigrana, Ph.D.
Bronx, NY - United States
2024

The Amygdala as Gateway and Gatekeeper to Lewy Body Co-pathology

David Fischer, M.D.
San Francisco, CA - United States
2024

Proteomic signatures of cognitive resilience in excitatory cortical neurons

Lauren Fish, Ph.D.
Ann Arbor, MI - United States
2024

Understanding Affective Symptoms in Dementia by Peripheral Immune Changes

Daniel Fisher, M.D., Ph.D.
Seattle, WA - United States
2024

Investigating aberrant cellular mechanics as early event of tau pathology

Martha Foiani, Ph.D.
London, United Kingdom
2024

Understanding the Negative Impact of APOE4 on Neural Responses to Estrogens

Karyn Frick, Ph.D.
Milwaukee, WI - United States
2024

The role of the CXCL9-11/CXCR3 cascade in frontotemporal dementia pathology

Nazaret Gamez, Ph.D.
Houston, TX - United States
2024

Lifecourse Vascular Contributions to Dementia Among Diverse Older Adults

Kristen George, Ph.D.
Davis, CA - United States
2024

The role of myelin in Alzheimer's Disease

Marios Georgiadis, Ph.D.
Stanford, CA - United States
2024

Contribution of Sleep Loss and Sex in AD-Related Pathogenesis

Nicole Gervais, Ph.D.
Groningen, Netherlands
2024

Reframing Alzheimer's Disease as a Developmental Disorder

Brian Gordon, Ph.D.
St. Louis, MS - United States
2024

METHODEM: Methodological consensus for complex interventions in dementia

Maud Graff, Ph.D.
Nijmegen, Netherlands
2024

Evidence-Based Speech-Language Intervention in Latinxs of Mexican Origin

Stephanie Grasso, Ph.D.
Austin, TX - United States
2024

In Vivo Roles of Rejuvenating Blood-Borne Factors in Amyloid-Beta Metabolism

Alejandro Borja Grau Perales, Ph.D.
New York, NY - United States
2024

Short Tandem Repeats as a Novel Genetic Driver of Alzheimer's Disease

Michael Guo, M.D., Ph.D.
Philadelphia, PA - United States
2024

Targeting Polyglutamylated Tubulin as an Early Treatment Strategy for AD

Torben Hausrat, Ph.D.
Hamburg, Germany
2024

1 2 3 4 5 6 7 8 9 10... >|